ESTRO Multidisciplinary Management of Breast Cancer 2017

Previous Page

Next Page

Page Background

Trials of radiotherapy after mastectomy and axillary dissection

1772 pN4+ women

Any first recurrence

Breast cancer mortality

Years since randomisation Years since randomisation

8.8%

9.3%

RT: Significant benefit